Core Viewpoint - Yanzhiwu has been recognized as a leading enterprise in the edible bird's nest industry, receiving the 2025 "Golden Lion" ESG award for its exemplary case in rural revitalization, showcasing its commitment to sustainable development and social responsibility [1][3][5] Group 1: ESG Practices and Achievements - Yanzhiwu has established rural employment factories in Guanghe County, providing significant job opportunities and contributing to poverty alleviation, with 277 individuals lifted out of poverty [3][5] - The company has been awarded the title of "Advanced Collective in Poverty Alleviation" in Fujian Province, reflecting its effective local support and collaboration efforts [3][5] - Yanzhiwu is the first listed company in the Chinese bird's nest industry, actively promoting a sustainable ESG framework and leading initiatives in green development [5][7] Group 2: Environmental Initiatives - The company is committed to reducing carbon emissions through the implementation of energy-efficient equipment and environmentally friendly production processes [5][7] - Yanzhiwu has developed a new generation of fresh stewed bird's nest products using eco-friendly packaging materials, significantly reducing packaging volume to promote energy conservation [5][8] - The company has received certifications for product carbon footprint and greenhouse gas verification, and was recognized as a "Green Factory" in Fujian Province [5][7] Group 3: Future Plans and Goals - Yanzhiwu plans to build the world's largest bird's nest factory by May 2024, aiming to lead the industry in smart manufacturing and green technology [7][8] - The company is focused on integrating ESG strategies with sustainable development, responding to national dual carbon goals and rural revitalization strategies [8]

Core Viewpoint - Yan Zhi Wu has received the "world's first patent authorization for the efficacy and application of bird's nest peptides," marking a significant advancement in the industry and establishing a benchmark for scientific validation and industrial transformation [1][11]. Group 1: Patent and Technology - The patent granted to Yan Zhi Wu is for a method of preparing bird's nest peptides that promote cell repair and provide high moisturizing and whitening effects (Patent No: ZL 2022 11398048.3) [1][4]. - The patented technology clarifies the enzymatic hydrolysis process of bird's nest peptides, revealing their properties such as moisturizing, whitening, and antioxidant effects, thus overcoming the industry's previous limitations of vague components and effects [3][4]. - The enzymatic hydrolysis process involves precise control to produce small molecular peptides with an average molecular weight of less than 1000 Da, enhancing the bioavailability of active ingredients [3][4]. Group 2: Research and Development - Yan Zhi Wu established a bird's nest peptide research center in January 2022, focusing on enzymatic technology, active ingredient research, and product development, achieving significant breakthroughs published in international journals [4]. - The company has received multiple industry awards, including the "Bird's Nest Peptide - Industry Innovation Award" in 2023, recognizing its contributions to the development of the bird's nest industry [4][5]. - In 2024, Yan Zhi Wu's bird's nest peptides were awarded the "Top 10 Chinese Innovative Raw Materials" and "Chinese Ace Ingredient Award," further solidifying its leadership in the field [4][8]. Group 3: Product Development - In 2022, Yan Zhi Wu launched its skincare brand "YAN PALACE," featuring small molecular bird's nest peptides as core ingredients, developing products like multi-effect facial masks and essence [8]. - The company was recognized by Frost & Sullivan as the "pioneer of bird's nest peptide skincare products" based on comparative research of Chinese skincare products [8][11]. - Yan Zhi Wu aims to provide healthier skincare experiences for women, promoting the concept of "bird's nest peptides advocating a new skin ecology" [8][9].

EF001 | 股東如對末期股息的稅項有任何疑問，務請諮詢彼等的專業顧問。 | | | | | --- | --- | --- | --- | | 有關進一步詳情請見公司日期為2025年4月16日的通函。 | | | | | 股東類型 | | 稅率 | 有關代預扣所得稅之更多補充 | | | | | （如適用） | | 非居民企業 | | | | | （非中國內地登記地址） | | 10% | 公司向名列H股股東名冊的非居 | | | | | 民企業股東派發現金股息時, 須按 | | | | | 10%的稅率代扣代繳企業所得稅。 | | | | | 任何以非個人股東名義（包括以香 | | | | | 港中央結算（代理人）有限公司、 | | | | | 其他代名人、代理或受託人、其他 | | | | | 組織或團體名義）登記的H股均被 | | | | | 視為非居民企業股東所持的股份 | | 非個人居民 | | | | | （非中國內地登記地址） | | 10% | 如H股個人股東為香港或澳門居民 | | | | | 或其他與中國就向彼等派發的現金 | | | | | 股息簽訂10%稅率的稅收協議的國 | | ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不會因本公告全部或任何部分內容而產生或因依 賴該等內容而引致的任何損失承擔任何責任。 XIAMEN YAN PALACE BIRD'S NEST INDUSTRY CO., LTD. 廈門燕之屋燕窩產業股份有限公司 （於中華人民共和國註冊成立的股份有限公司） 根據《中華人民共和國公司法》及公司章程的規定，本次年度股東大會於2025年5 月9日（星期五）上午十時正（香港時間）假座中國福建省廈門市思明區蓮前街道前 埔路188號才子匯22樓舉行。年度股東大會由董事長黃健先生主持。 董事會欣然宣佈，於年度股東大會上，年度股東大會通告所載之所有建議決議案 均已獲股東以投票表決方式正式通過。 （股份代號：1497） 茲提述廈門燕之屋燕窩產業股份有限公司（「本公司」）日期為2025年4月16日之 2024年年度股東大會（「年度股東大會」）通告及本公司日期為2025年4月16日之通 函（「通函」）。除另有界定者外，本公告所用詞彙與通函所界定者具有相同涵義。 於年度股東大會日期，本公司已發行股份總數為46 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚 賴該等內容而引致的任何損失承擔任何責任。 XIAMEN YAN PALACE BIRD'S NEST INDUSTRY CO., LTD. 廈門燕之屋燕窩產業股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：1497） 持續關連交易 產品銷售及採購框架協議 產品銷售及採購框架協議 董事會欣然宣佈，於2025年4月30日，為開拓本集團的新市場及推出新產品， 本公司、深圳燕之屋及新加坡燕之屋就銷售燕窩產品訂立產品銷售及採購框架 協議。 根據產品銷售及採購框架協議，截至2025年12月31日止年度，向深圳燕之屋及 新加坡燕之屋提供燕窩相關產品的相關年度上限總額不得超過人民幣12.0百萬 元。 上市規則的涵義 於本公告日期，深圳燕之屋及新加坡燕之屋由黃俊豪先生及黃丹華女士分別擁 有10%及15%權益。黃俊豪先生及黃丹華女士均為本公司控股股東之一黃先生 的家庭成員。因此，根據上市規則第14A.07(5)條，黃俊豪先生及黃丹華女士均 為 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不會因本公告全部或任何部分內容而產生或因依 賴該等內容而引致的任何損失承擔任何責任。 XIAMEN YAN PALACE BIRD'S NEST INDUSTRY CO., LTD. 廈門燕之屋燕窩產業股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：1497） 公 告 根 據 H 股激勵計劃授出信託受益權份額 茲提述本公司日期為2024年1月12日及2024年12月4日的公告、日期為2024年3月 7日的2024年第一次臨時股東大會通函（「通函」）、本公司日期為2024年3月25日 的投票表決結果公告，內容有關（其中包括）審議及批准本公司的H股激勵計劃以 及於2025年4月16日刊發的2024年年報。除文義另有所指外，本公告所用詞彙與 通函附錄一所載H股激勵計劃所界定者具有相同涵義。 根據H股激勵計劃授出信託受益權份額 董事會欣然宣佈，於2025年4月30日，除於2024年12月向70名合資格人士授出相 當於6,284,500股相關H股的信託受益權份額（包括向關連人 ...

以下文章来源于侃见财经 ，作者侃见财经 侃见财经 . 看见不一样的财经！ 这是燕之屋近五年以来首次出现"增收不增利"的情形。2021年至2023年，燕之屋的净利润分别为1.64亿 元、1.88亿元、1.97亿元，同比增速分别为34.81%、14.42%、4.93%。 与此同时，燕之屋在资本市场的表现也不尽如人意，截至4月23日收盘，其股价报6.53港元，相较于去年 7月的高点，累计跌幅已达57.4%，相较于IPO发行价（9.7港元）下跌32.7%，总市值缩水至30.4亿港元。 值得一提的是，就在前不久，燕之屋高调官宣万科集团创始人王石，成为其最新产品——"全球首款男 人燕窝"总裁碗燕的品牌代言人，引起市场关注及讨论。 这款总裁碗燕的售价高达3168元，但截至4月22日，在燕之屋天猫官方旗舰店上，这款总裁碗燕的销量 颇为惨淡，仅有65人付款。 本文转载自侃见财经 值班编辑 | 江江 视觉 | 诺言 王石没能"拯救"燕之屋。 近日，号称"燕窝第一股"的燕之屋（01497.HK）披露了最新财报，其中显示，2024年全年实现营收20.5 亿元，同比增长4.37%；净利润为1.6亿元，同比大幅下降24.18%。 | | ...

Core Viewpoint - Vanke Group's founder Wang Shi endorses a new high-priced product "President Bowl Bird's Nest," which has sparked market discussions but has underperformed in sales despite significant marketing efforts [2][5][6]. Group 1: Product and Market Positioning - "President Bowl Bird's Nest" is marketed as the world's first bird's nest product for men, priced at 528 yuan per bowl and 3168 yuan for a six-pack, significantly higher than the average bird's nest price of 174 yuan per bowl [2][6]. - The product targets the high-end male health supplement market, claiming to include eight traditional Chinese medicinal ingredients, but faces skepticism from male consumers who traditionally associate bird's nest with women's beauty and health [6][8]. Group 2: Sales Performance and Marketing Strategy - As of April 24, the product has sold only 84 units on Tmall, with even lower sales on other platforms like JD and Douyin, indicating a disconnect between high pricing and market acceptance [5][6]. - Despite heavy investment in marketing, including partnerships with multiple celebrities, the company's profit has declined by 24.18% year-on-year to 160 million yuan, while marketing expenses accounted for 32.7% of total revenue [9][10]. Group 3: Industry Challenges and Future Outlook - The bird's nest industry is experiencing a slowdown, with market growth rates dropping from 15% to 12% in 2023, highlighting the need for innovation and differentiation in products [12]. - Analysts suggest that the male health supplement market could reach 99.6 billion yuan by 2025, but Vanke Group must overcome traditional perceptions and effectively educate male consumers to succeed [12].

Core Viewpoint - Xiamen Yan's Nest Industry Co., Ltd. (referred to as "Yan's Nest") has entered the capital market after multiple IPO attempts, but its performance post-listing has been weak, with revenue growth accompanied by a significant decline in net profit in 2024 [1] Financial Performance - In 2024, Yan's Nest reported a revenue increase of 4.37% year-on-year to 2.05 billion yuan, while net profit plummeted by 24.18% to 160 million yuan, marking the first time net profit margin fell below 10% [1] - The sales revenue from pure bird's nest products was 1.795 billion yuan, accounting for 87.6% of total revenue, with a mere 0.06% growth year-on-year [2] Marketing and Cost Structure - Sales and distribution expenses surged by 19% year-on-year to 670 million yuan, representing 32.7% of total revenue, primarily due to high-profile endorsements and increased promotional costs [2] - The strategy of relying on celebrity endorsements and e-commerce channels has led to a significant increase in promotional expenses, with over 60% of revenue coming from e-commerce [2] Competitive Landscape - Yan's Nest faces intensified competition, with brands like Xiaoxian Stewed and pharmaceutical-backed companies entering the health market, while prices for ready-to-eat bird's nest products have dropped significantly [3] - The company's attempt to diversify with "bird's nest+" products has seen limited success, with these products only accounting for 11.3% of revenue and lacking technological barriers [3] Consumer Trust and Market Dynamics - The industry continues to grapple with trust issues, particularly following past incidents related to product safety, which have led to consumer skepticism about quality [3] - The core customer base is shifting, with younger consumers gravitating towards more affordable health products, while high-end customers are increasingly attracted to competing brands [3] Strategic Challenges - Yan's Nest's strategies, such as cost reduction through smart factories and expanding into county markets, are unlikely to reverse the profit decline in the short term [3] - Without significant breakthroughs in research and development or product innovation by 2025, the company's leading position in the market may be at risk [3]

| 股東如對末期股息的稅項有任何疑問，務請諮詢彼等的專業顧問。 | | | | | --- | --- | --- | --- | | 有關進一步詳情請見公司日期為2025年4月16日的通函。 | | | | | 股東類型 | | 稅率 | 有關代預扣所得稅之更多補充 | | | | | （如適用） | | 非居民企業 | | | | | （非中國內地登記地址） | | 10% | 公司向名列H股股東名冊的非居 | | | | | 民企業股東派發現金股息時, 須按 | | | | | 10%的稅率代扣代繳企業所得稅。 | | | | | 任何以非個人股東名義（包括以香 | | | | | 港中央結算（代理人）有限公司、 | | | | | 其他代名人、代理或受託人、其他 | | | | | 組織或團體名義）登記的H股均被 | | | | | 視為非居民企業股東所持的股份 | | 非個人居民 | | | | | （非中國內地登記地址） | | 10% | 如H股個人股東為香港或澳門居民 | | | | | 或其他與中國就向彼等派發的現金 | | | | | 股息簽訂10%稅率的稅收協議的國 | | | | | ...